全文获取类型
收费全文 | 5449篇 |
免费 | 383篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 134篇 |
妇产科学 | 137篇 |
基础医学 | 802篇 |
口腔科学 | 113篇 |
临床医学 | 478篇 |
内科学 | 1278篇 |
皮肤病学 | 153篇 |
神经病学 | 663篇 |
特种医学 | 205篇 |
外科学 | 479篇 |
综合类 | 8篇 |
一般理论 | 1篇 |
预防医学 | 297篇 |
眼科学 | 58篇 |
药学 | 402篇 |
中国医学 | 26篇 |
肿瘤学 | 625篇 |
出版年
2024年 | 11篇 |
2023年 | 90篇 |
2022年 | 178篇 |
2021年 | 310篇 |
2020年 | 197篇 |
2019年 | 252篇 |
2018年 | 235篇 |
2017年 | 175篇 |
2016年 | 205篇 |
2015年 | 227篇 |
2014年 | 264篇 |
2013年 | 343篇 |
2012年 | 490篇 |
2011年 | 454篇 |
2010年 | 230篇 |
2009年 | 217篇 |
2008年 | 362篇 |
2007年 | 343篇 |
2006年 | 318篇 |
2005年 | 244篇 |
2004年 | 242篇 |
2003年 | 197篇 |
2002年 | 165篇 |
2001年 | 26篇 |
2000年 | 12篇 |
1999年 | 13篇 |
1998年 | 28篇 |
1997年 | 12篇 |
1996年 | 12篇 |
1995年 | 10篇 |
1994年 | 7篇 |
1993年 | 7篇 |
1992年 | 5篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1984年 | 1篇 |
1983年 | 3篇 |
1981年 | 2篇 |
1979年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有5891条查询结果,搜索用时 187 毫秒
111.
112.
113.
Carla Sappino Ludovica Primitivo Martina De Angelis Francesco Righi Federica Di Pietro Marika Iannoni Luciano Pilloni Stefano Vecchio Ciprioti Lorenza Suber Alessandra Ricelli Giuliana Righi 《RSC advances》2020,10(50):29688
A linear β-amino alcohol ligand, previously found to be a very efficient catalyst for enantioselective addition of dialkylzinc to aromatic aldehydes, has been anchored on differently functionalized superparamagnetic core–shell magnetite–silica nanoparticles (1a and 1b). Its catalytic activity in the addition of dialkylzinc to aldehydes has been evaluated, leading to promising results, especially in the case of 1b for which the recovery by simple magnetic decantation and reuse was successfully verified.The catalytic activity of a linear β-amino alcohol ligand anchored on functionalized magnetite/silica core–shell nanoparticles has been evaluated in the addition of dialkylzinc to aldehydes leading to promising results. 相似文献
114.
115.
116.
Carlos Mota Dario Puppi Federica Chiellini Emo Chiellini 《Journal of tissue engineering and regenerative medicine》2015,9(3):174-190
‘Additive manufacturing’ (AM) refers to a class of manufacturing processes based on the building of a solid object from three‐dimensional (3D) model data by joining materials, usually layer upon layer. Among the vast array of techniques developed for the production of tissue‐engineering (TE) scaffolds, AM techniques are gaining great interest for their suitability in achieving complex shapes and microstructures with a high degree of automation, good accuracy and reproducibility. In addition, the possibility of rapidly producing tissue‐engineered constructs meeting patient's specific requirements, in terms of tissue defect size and geometry as well as autologous biological features, makes them a powerful way of enhancing clinical routine procedures. This paper gives an extensive overview of different AM techniques classes (i.e. stereolithography, selective laser sintering, 3D printing, melt–extrusion‐based techniques, solution/slurry extrusion‐based techniques, and tissue and organ printing) employed for the development of tissue‐engineered constructs made of different materials (i.e. polymeric, ceramic and composite, alone or in combination with bioactive agents), by highlighting their principles and technological solutions. Copyright © 2012 John Wiley & Sons, Ltd. 相似文献
117.
118.
119.
Federica Collino Stefania Bruno Danny Incarnato Daniela Dettori Francesco Neri Paolo Provero Margherita Pomatto Salvatore Oliviero Ciro Tetta Peter J. Quesenberry Giovanni Camussi 《Journal of the American Society of Nephrology : JASN》2015,26(10):2349-2360
Phenotypic changes induced by extracellular vesicles have been implicated in mesenchymal stromal cell–promoted recovery of AKI. MicroRNAs are potential candidates for cell reprogramming toward a proregenerative phenotype. The aim of this study was to evaluate whether microRNA deregulation inhibits the regenerative potential of mesenchymal stromal cells and derived extracellular vesicles in a model of glycerol-induced AKI in severe combined immunodeficient mice. We generated mesenchymal stromal cells depleted of Drosha to alter microRNA expression. Drosha-knockdown cells produced extracellular vesicles that did not differ from those of wild-type cells in quantity, surface molecule expression, and internalization within renal tubular epithelial cells. However, these vesicles showed global downregulation of microRNAs. Whereas wild-type mesenchymal stromal cells and derived vesicles administered intravenously induced morphologic and functional recovery in AKI, the Drosha-knockdown counterparts were ineffective. RNA sequencing analysis showed that kidney genes deregulated after injury were restored by treatment with mesenchymal stromal cells and derived vesicles but not with Drosha-knockdown cells and vesicles. Gene ontology analysis showed in AKI an association of downregulated genes with fatty acid metabolism and upregulated genes with inflammation, matrix-receptor interaction, and cell adhesion molecules. These alterations reverted after treatment with wild-type mesenchymal stromal cells and extracellular vesicles but not after treatment with the Drosha-knockdown counterparts. In conclusion, microRNA depletion in mesenchymal stromal cells and extracellular vesicles significantly reduced their intrinsic regenerative potential in AKI, suggesting a critical role of microRNAs in recovery after AKI. 相似文献
120.
Giorgina Barbara Piccoli Gianfranca Cabiddu Rossella Attini Federica Neve Vigotti Stefania Maxia Nicola Lepori Milena Tuveri Marco Massidda Cecilia Marchi Silvia Mura Alessandra Coscia Marilisa Biolcati Pietro Gaglioti Michele Nichelatti Luciana Pibiri Giuseppe Chessa Antonello Pani Tullia Todros 《Journal of the American Society of Nephrology : JASN》2015,26(8):2011-2022
CKD is increasingly prevalent in pregnancy. In the Torino-Cagliari Observational Study (TOCOS), we assessed whether the risk for adverse pregnancy outcomes is associated with CKD by comparing pregnancy outcomes of 504 pregnancies in women with CKD to outcomes of 836 low-risk pregnancies in women without CKD. The presence of hypertension, proteinuria (>1 g/d), systemic disease, and CKD stage (at referral) were assessed at baseline. The following outcomes were studied: cesarean section, preterm delivery, and early preterm delivery; small for gestational age (SGA); need for neonatal intensive care unit (NICU); new onset of hypertension; new onset/doubling of proteinuria; CKD stage shift; “general” combined outcome (preterm delivery, NICU, SGA); and “severe” combined outcome (early preterm delivery, NICU, SGA). The risk for adverse outcomes increased across stages (for stage 1 versus stages 4–5: “general” combined outcome, 34.1% versus 90.0%; “severe” combined outcome, 21.4% versus 80.0%; P<0.001). In women with stage 1 CKD, preterm delivery was associated with baseline hypertension (odds ratio [OR], 3.42; 95% confidence interval [95% CI], 1.87 to 6.21), systemic disease (OR, 3.13; 95% CI, 1.51 to 6.50), and proteinuria (OR, 3.69; 95% CI, 1.63 to 8.36). However, stage 1 CKD remained associated with adverse pregnancy outcomes (general combined outcome) in women without baseline hypertension, proteinuria, or systemic disease (OR, 1.88; 95% CI, 1.27 to 2.79). The risk of intrauterine death did not differ between patients and controls. Findings from this prospective study suggest a “baseline risk” for adverse pregnancy-related outcomes linked to CKD. 相似文献